METRICA Co.,Ltd

Based in Japan, METRICA Co. ,Ltd is engaged in developing innovative AI-driven solutions focused on healthcare, nursing, and welfare sectors to enhance patient care and operational efficiency. Founded in 2018, METRICA Co. ,Ltd, headquartered in Tokyo, Japan, specializes in AI system development for the healthcare industry.

The company has completed two deals, with its most recent funding round being a Series B on August 11, 2021, raising JPY 100 million from investors including D4V and SFC Forum. The company is not a subsidiary and has not undergone any significant pivots in its business strategy. METRICA Co. ,Ltd specializes in innovative system development that leverages artificial intelligence (AI) within the healthcare, nursing, and welfare sectors.

Core offerings include a remote management support system for peritoneal dialysis patients, incorporating real-time monitoring for prompt healthcare responses. Additionally, METRICA provides an AI image analysis system enhancing diagnostic accuracy in home healthcare through advanced image recognition technology, coupled with a comprehensive telemedicine support system facilitating remote medical services. The company primarily serves healthcare providers and institutions in Japan, with plans for international market expansion. The revenue structure of METRICA Co.

,Ltd is based on B2B transactions with healthcare institutions, utilizing subscription models for software services and licensing agreements for proprietary technology. Client engagements often include service level agreements that outline the scope of services such as ongoing support and updates. Key products include the PD Doctor's Eye and AI image analysis systems, with pricing plans tailored to the complexity of deployment and the needs of healthcare providers. Following a successful Series B funding round on August 11, 2021, where METRICA raised JPY 100 million, the company aims to utilize the funds to introduce its services to medical institutions and home-visit nursing stations across Japan, promoting clinical research and model creation.

METRICA plans to develop new products to enhance its AI capabilities and expand its reach into international markets, targeting areas with aging populations and pressing healthcare challenges.